In pancreatic cancer, NLRP3 and its mediated inflammatory response are considered to significantly impact progression and occurrence of tumor (Lutz et al., 2023; Boone et al., 2019; Zheng and Liu, 2022). This evidence concerns the gene NLRP3 and familial pancreatic carcinoma.